Merck faces high-stakes decision on Moderna acquisition
Merck's reliance on Keytruda for nearly half its sales is pushing the company to consider a bold move-acquiring Moderna for $210-$215 per share to secure next-generation cancer vaccine technology
View Story
Wall Street bets on technology and industrials to outpace the S&P 500
Wall Street analysts expect technology and industrials to deliver stronger gains than the S&P 500 through 2027, with sector ETFs like VGT and VIS offering focused access but also unique risks for investors seeking higher returns
Federal Reserve delivers first rate hike in three years as markets react
The Federal Reserve raised its benchmark rate to 3.50%-3.75% for the first time since 2023, sending stocks lower and pushing Treasury yields higher as investors brace for tighter borrowing conditions and potential further hikes.
Microsoft dividend hike delivers higher yield for shareholders
Microsoft is raising its quarterly dividend by 8 percent to $0.98 per share, increasing the annual payout and offering investors a higher yield as the company doubles down on cloud and AI spending
